David Gau

University of Pittsburgh — United States

Materials Science · Physical Sciences

26h-index1.7kcitations130works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Crystallization and Solubility Studies(37), X-ray Diffraction in Crystallography(37), Cellular Mechanics and Interactions(22), Synthesis and characterization of novel inorganic/organometallic compounds(16), Organoboron and organosilicon chemistry(16)

Publications130 total

Introduction to the Special Issue “Cytoskeleton Regulation of Mitochondrial Dynamics”
Cytoskeleton·2026
Mitochondria and the Actin Cytoskeleton in Neurodegeneration
Cytoskeleton·2026· 1 citedOpen Access
Molecular insights into Profilin1-dependent regulation of cellular phosphatidylinositol-(4,5)-bisphosphate
2025Open Access
Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinoma
Journal of Biological Chemistry·2025Open Access
Survivin as a Multifaceted Oncogenic Driver and Therapeutic Target in Renal Cell Carcinoma
2025Open Access
Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinoma
2025Open Access
Abstract 2067 Actin-Regulatory Protein Profilin1 Plays an Important Role in Lipid Homeostasis
Journal of Biological Chemistry·2025Open Access
Damage sensing through TLR9 regulates inflammatory and antiviral responses during influenza infection
Mucosal Immunology·2025· 5 citedOpen Access
Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner
Molecular Biology of the Cell·2024· 1 citedOpen Access
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer
2024· 1 citedOpen Access
mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration
Molecular Biology of the Cell·2024· 1 citedOpen Access
40 Preclinical evaluation of a novel dendritic cell vaccine for kidney cancer
The Oncologist·2024· 1 citedOpen Access
Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer
2024
Haplo‐insufficiency of <scp>Profilin1</scp> in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosis
Cytoskeleton·2024· 1 citedOpen Access
mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration
2023· 1 citedOpen Access
Actin-binding protein profilin1 is an important determinant of cellular phosphoinositide control
Journal of Biological Chemistry·2023· 4 citedOpen Access
Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner
2023Open Access
Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosis
2023· 1 citedOpen Access
Vascular endothelial cell-specific disruption of the<i>profilin1</i>gene leads to severe multiorgan pathology and inflammation causing mortality
PNAS Nexus·2023· 8 citedOpen Access
Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer
Journal of Biological Chemistry·2023· 12 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Partha Roy(26), Tsuyoshi Kato(19), Antoine Baceiredo(18), Ricardo Rodrı́guez(16), Nathalie Saffon‐Merceron(11), Fernando P. Cossío(8), Abel de Cózar(7), Nathalie Saffon‐Merceron(6), David Ryan Koes(6), Yohan Contie(4), Thibault Troadec(4), Karinne Miqueu(4), Jean‐Marc Sotiropoulos(4), Vicenç Branchadell(4), Abigail Allen(4), David N. Boone(4), Daisuke Hashizume(3), Zhijie Ding(3), William Veon(3), Sanjeev G. Shroff(3)